Literature DB >> 22703895

Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery.

Ilse G C Hermsen1, Thomas M A Kerkhofs, Gijsbert den Butter, Job Kievit, Casper H J van Eijck, Els J M Nieveen van Dijkum, Harm R Haak.   

Abstract

BACKGROUND: The low incidence rate of adrenocortical carcinoma (ACC) requires a multidisciplinary approach in which surgery plays an essential role because complete resection of the primary tumor is the only chance of cure. To improve patient care, insight into operative results within the ACC population is essential. In 2007, a Dutch Adrenal Network Registry was created covering care and outcome of patients treated for ACC in the Netherlands since 1965. Using this database, we performed a study (1) to gain insight into surgical performance in the Netherlands and (2) to compare operative data with international literature.
METHODS: Data on patients treated from 1965 until January 2008 were studied. The following data were collected: age, gender, functionality of the tumor, stage at diagnosis, operative procedure, completeness of surgery, disease recurrence, adjuvant mitotane therapy, and recurrence-free and overall survival (OS).
RESULTS: A total of 175 patients were studied, of whom 149 underwent surgery. Patients with complete resection had significantly longer OS times than patients with incomplete resection (P = .010). Patients operated on in a Dutch Adrenal Network center had significantly longer duration of OS in both univariate (P = .011) and multivariate analysis (P = .014). A significantly greater OS was observed for operated stage IV patients compared with nonoperated patients (P = .002).
CONCLUSION: Our data suggest the relevance of national cooperation and centralized surgery in ACC. For selected patients with stage IV disease, surgery can be beneficial in extending survival. On the basis of the retrospective analysis, operative ACC in the Netherlands can and will be improved.
Copyright © 2012. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22703895     DOI: 10.1016/j.surg.2012.02.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.

Authors:  Brian K Bednarski; Mouhammed Amir Habra; Alexandria Phan; Denai R Milton; Christopher Wood; Nicholas Vauthey; Douglas B Evans; Matthew H Katz; Chaan S Ng; Nancy D Perrier; Jeffrey E Lee; Elizabeth G Grubbs
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 2.  Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy-a population-based study and review of the literature.

Authors:  S Atallah; H Al-Assaf; Y Xu; S El-Sayed
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

3.  Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network.

Authors:  M H T Ettaieb; J C Duker; R A Feelders; E P M Corssmit; C W Menke-van der Houven van Oordt; H J L M Timmers; M N Kerstens; J W Wilmink; P M Zelissen; B Havekes; H R Haak
Journal:  Horm Cancer       Date:  2016-07-15       Impact factor: 3.869

Review 4.  Surgical approach to patients with hypercortisolism.

Authors:  Colleen M Kiernan; Carmen C Solórzano
Journal:  Gland Surg       Date:  2020-02

5.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

Authors:  Montserrat Ayala-Ramirez; Sina Jasim; Lei Feng; Shamim Ejaz; Ferhat Deniz; Naifa Busaidy; Steven G Waguespack; Aung Naing; Kanishka Sircar; Christopher G Wood; Lance Pagliaro; Camilo Jimenez; Rena Vassilopoulou-Sellin; Mouhammed Amir Habra
Journal:  Eur J Endocrinol       Date:  2013-10-23       Impact factor: 6.664

6.  Implications of Conversion during Attempted Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma.

Authors:  Olivia M Delozier; Zachary E Stiles; Benjamin W Deschner; Justin A Drake; Jeremiah L Deneve; Evan S Glazer; Miriam W Tsao; Danny Yakoub; Paxton V Dickson
Journal:  Ann Surg Oncol       Date:  2020-07-11       Impact factor: 5.344

7.  Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database.

Authors:  Paula Marincola Smith; Colleen M Kiernan; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Jason Prescott; Timothy Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivka Shenoy; John Phay; Lawrence A Shirley; Ryan C Fields; Linda Jin; Sharon Weber; Ahmed Salem; Jason Sicklick; Shady Gad; Adam Yopp; John Mansour; Quan-Yang Duh; Natalie Seiser; Konstantinos Votanopoulos; Edward A Levine; George Poultsides; Carmen C Solórzano
Journal:  Ann Surg Oncol       Date:  2018-06-04       Impact factor: 5.344

8.  Adrenocortical carcinoma: modern management and evolving treatment strategies.

Authors:  Lucas A McDuffie; Rachel D Aufforth
Journal:  Int J Endocr Oncol       Date:  2016-04-08

Review 9.  Laparoscopic Adrenalectomy for Large Adrenocortical Carcinoma.

Authors:  Norman Oneil Machado; Hani Al Qadhi; Khalifa Al Wahaibi; Syed G Rizvi
Journal:  JSLS       Date:  2015 Jul-Sep       Impact factor: 2.172

10.  Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.

Authors:  Zlatibor Loncar; Vladimir Djukic; Vladan Zivaljevic; Tatjana Pekmezovic; Aleksandar Diklic; Svetislav Tatic; Dusko Dundjerovic; Branislav Olujic; Nikola Slijepcevic; Ivan Paunovic
Journal:  BMC Urol       Date:  2015-05-27       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.